103 related articles for article (PubMed ID: 1652128)
1. The impact of nucleolar organizer regions for the lymph node spread and prognosis of invasive ductal mammary carcinoma.
Bockmühl U; Theissig F; Dimmer V; Kunze KD
Pathol Res Pract; 1991 May; 187(4):437-43. PubMed ID: 1652128
[TBL] [Abstract][Full Text] [Related]
2. Grading and prognosis of invasive ductal mammary carcinoma by nuclear image analysis in tissue sections.
Kunze KD; Haroske G; Dimmer V; Meyer W; Theissig F
Pathol Res Pract; 1989 Nov; 185(5):689-93. PubMed ID: 2560542
[TBL] [Abstract][Full Text] [Related]
3. Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis.
Lipponen P; Aaltomaa S; Papinaho S; Syrjänen K
Pathol Res Pract; 1993 Nov; 189(9):1030-5. PubMed ID: 8302721
[TBL] [Abstract][Full Text] [Related]
4. ["Nucleolar organizer regions" as a factor for the prognosis of laryngeal cancer?].
Bockmühl U; Bockmühl F; Dimmer V; Kunze KD
Laryngorhinootologie; 1992 Mar; 71(3):137-41. PubMed ID: 1596315
[TBL] [Abstract][Full Text] [Related]
5. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
11. Prediction of recurrence and nucleolar features in node-negative breast carcinoma, ductal type, grade II. An ultrastructural study.
Lloreta J; Ferrer D; Corominas JM; Pavesi M; Serrano S; Mackay B
Virchows Arch; 2002 Mar; 440(3):280-4. PubMed ID: 11889598
[TBL] [Abstract][Full Text] [Related]
12. Validation of the S classification of sentinel lymph node and microanatomic location of sentinel lymph node metastases to predict additional lymph node involvement and overall survival in breast cancer patients.
Fink AM; Wondratsch H; Lass H; Janauer M; Sevelda P; Salzer H; Jurecka W; Ulrich W; Chott A; Steiner A
Ann Surg Oncol; 2011 Jun; 18(6):1691-7. PubMed ID: 21249455
[TBL] [Abstract][Full Text] [Related]
13. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
14. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer.
Aaltomaa S; Lipponen P; Syrjänen K
Pathol Res Pract; 1993 May; 189(4):416-21. PubMed ID: 8351243
[TBL] [Abstract][Full Text] [Related]
16. Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Comparison with classifications and prognosis.
Aubele M; Auer G; Gais P; Jütting U; Rodenacker K; Voss A
Pathol Res Pract; 1994 Feb; 190(2):129-37. PubMed ID: 7520163
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
20. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
